Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
申请人:Ares Trading SA
公开号:EP2508526A1
公开(公告)日:2012-10-10
The present invention is directed to compounds of Formula (I) below, which are antagonists to the chemoattractant cytokine receptor 2 (CCR2), and/or 5 (CCR5), pharmaceutical compositions, and methods for use thereof.
本发明涉及以下式(I)的化合物,这些化合物是趋化因子细胞因子受体2(CCR2)和/或5(CCR5)的拮抗剂,以及其药物组合物和使用方法。